Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
Phase of Trial: Phase I/II
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Capecitabine (Primary) ; Paclitaxel (Primary) ; Trastuzumab (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 18 Dec 2017 Status changed from completed to discontinued.
- 13 May 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Nov 2014 New trial record